Interim report 2026
Filed with HKEX · Stock code 6915 · · 51 pages · English
Corporate Information 2 Financial Highlights 4 Management Discussion and Analysis 5 Other Information 22 Report on Review of Condensed Consolidated Financial Statements 28 Condensed Consolidated Statements of Profit or Loss and Other Comprehensive Income 30 Condensed Consolidated Statement of Financial Position 31 Condensed Consolidated Statement of Changes in Equity 33 Condensed Consolidated Stat
Jiangxi Institute of Biological Products Inc. on 6ix
Earlier from Jiangxi Institute of Biological Products
- New Arrangements of Electronic Dissemination of Corporate Communications
- New Arrangements on Dissemination of Corporate Communications
- JIANGXI BIO Announced 2026 Interim Results
- Jiangxi Bio's Veterinary Tetanus Antitoxin Production Line Officially Commenced Production,Accelerating Commercialization of the Animal Antiserum Portfolio
- Announcement of allotment results
Later from Jiangxi Institute of Biological Products
All Jiangxi Institute of Biological Products news releasesFollow Jiangxi Institute of Biological Products into a list and get an email when it puts out news.
Follow Jiangxi Institute of Biological Products